Morbus Parkinson / Parkinson's Disease (PD)

Navigation

Parkinson's disease (PD) affects more than six million people worldwide, and its prevalence is increasing.
Grotemeyer et al. 2022 Front. Immunol. 13: 878771

Cardinal motor impairment and alfa-synucleinopathy are the characteristic features of Parkinson’s Disease
Dogra et al. 2021 Cellular and Molecular Neurobiology doi: 10.1007/s10571-021-01066-7

Morbus Parkinson / Parkinson's Disease (PD) is the second most prevalent neurodegenerative disorder, expected to affect more than 7-10 million people worldwide by 2030
Marras et al. 2018 NPJ Parki…

References (Sources)

A timeline for Parkinson's disease
Hawkes et al. 2020 Park. Relat. Disord. 16: 79-84
Review
Gut microbiota dysfunction as reliable non-invasive early diagnostic biomarkers in the pathophysiology of Parkinson’s disease: a critical review
Nair et al. 2018 J Neurogastroenterol Motil 24(1): 30
Microbiome-gut-brain axis and toll-like receptors in Parkinson’s disease
Caputi & Giron 2018
Review
Parkinson disease epidemiology, pathology, genetics, and pathophysiology
Simon et al. 2020 Clin Geriatr Med 36(1): 1-12
Parkinson’s Disease
Kalia & Lang 2015 Lancet 386(9996): 896-912
Review
Pathoanatomy of Parkinson’s Disease
Braak & Braak 2000 J Neurol 247 (Suppl 2): II3-II10
The challenge and opportunity to diagnose Parkinson’s disease in midlife
Kilzheimer et al. 2019 Front Neurol 10(1328)
Review

AI Chat

11/5/2026

Chat with our artificial intelligence:

Start chat!

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Morbus Parkinson / Parkinson's Disease (PD)

Navigation

Contents

References (Sources)

AI Chat

Links

Welcome to meRfi Microbiome!